November 7, 2015 – Excerpt from NewsOK:
A $500,000 investment from the i2E Inc.-managed Oklahoma Seed Capital Fund recently led a $1.1 million financing round in Oklahoma City-based Biolytx Pharmaceuticals Corp.
Biolytx is developing a drug designed to promote wound healing and kill antibiotic resistant bacteria.
This latest financing also included $200,000 from i2E-managed SeedStep Angels group, $250,000 from an Oklahoma venture capital fund and $150,000 in investment by Biolytx management.
Full article available here: http://newsok.com/article/5458808